Literature DB >> 30726845

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus.

Silvio Danese1, Matthieu Allez2, Ad A van Bodegraven3, Iris Dotan4,5, Javier P Gisbert6, Ailsa Hart7, Peter L Lakatos8,9, Fernando Magro10, Laurent Peyrin-Biroulet11, Stefan Schreiber12, Dino Tarabar13, Stephan Vavricka14, Jonas Halfvarson15, Séverine Vermeire16.   

Abstract

BACKGROUND: The authors aimed to conduct an extensive literature review and consensus meeting to identify unmet needs in ulcerative colitis (UC) and ways to overcome them. UC is a relapsing and remitting inflammatory bowel disease with varied, and changing, incidence rates worldwide. UC has an unpredictable disease course and is associated with a high health economic burden. During 2016 and 2017, a panel of experts was convened to identify, discuss and address areas of unmet need in UC.
METHODS: PubMed and Cochrane Library databases were searched for relevant articles describing studies performed in patients with UC. These findings were used to generate a set of statements relating to unmet needs in UC. Consensus on these statements was then sought from a panel of 9 expert gastroenterologists using a modified Delphi review process that consisted of anonymous surveys followed by live meetings.
RESULTS: In 2 literature reviews, over 5,000 unique records were identified and a total of 138 articles were fully reviewed. These were used to consider 26 areas of unmet need, which were explored in 2 face-to-face meetings, in which the statements were debated and amended, resulting in consensus on 30 final statements. The unmet needs identified were categorised into 7 areas: impact of UC on patients' daily life; importance of early diagnosis and treatment; drawbacks of existing treatments; urgent need for new treatments; and disease-, practice- or patient-focused unmet needs.
CONCLUSIONS: These expert group meetings found a number of areas of unmet needs in UC, which is an important first step in tackling them in the future. Future research and development should be focused in these areas for the management of patients with UC.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Consensus panel; Delphi process; Systematic literature review; Ulcerative colitis; Unmet needs

Mesh:

Year:  2019        PMID: 30726845     DOI: 10.1159/000496739

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  16 in total

1.  Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use.

Authors:  Danielle Bargo; Theo Tritton; Joseph C Cappelleri; Marco DiBonaventura; Timothy W Smith; Takanori Tsuchiya; Sean Gardiner; Irene Modesto; Tim Holbrook; Daniel Bluff; Taku Kobayashi
Journal:  Inflamm Intest Dis       Date:  2021-11-17

2.  MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases.

Authors:  Wayne J G Hellstrom; Radboud J E M Dolhain; Timothy E Ritter; Timothy R Watkins; Sarah J Arterburn; Goele Dekkers; Angi Gillen; Caroline Tonussi; Leen Gilles; Alessandra Oortwijn; Katrien Van Beneden; Dick E de Vries; Suresh C Sikka; Dirk Vanderschueren; Walter Reinisch
Journal:  Adv Ther       Date:  2022-05-25       Impact factor: 4.070

3.  Ilex rotunda Thunb Protects Against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Restoring the Intestinal Mucosal Barrier and Modulating the Oncostatin M/Oncostatin M Receptor Pathway.

Authors:  Yao Li; Xu Yang; Jia-Ni Yuan; Rui Lin; Yun-Yuan Tian; Yu-Xin Li; Yan Zhang; Xu-Fang Wang; Yan-Hua Xie; Si-Wang Wang; Xiao-Hui Zheng
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

4.  Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.

Authors:  William J Sandborn; Brian G Feagan; Stephen Hanauer; Severine Vermeire; Subrata Ghosh; Wenzhong J Liu; AnnKatrin Petersen; Lorna Charles; Vivian Huang; Keith Usiskin; Douglas C Wolf; Geert D'Haens
Journal:  J Crohns Colitis       Date:  2021-07-05       Impact factor: 9.071

Review 5.  Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.

Authors:  Alex Al Khoury; Bhairavi Balram; Talat Bessissow; Waqqas Afif; Lorant Gonczi; Maria Abreu; Peter L Lakatos
Journal:  Dig Dis Sci       Date:  2021-05-21       Impact factor: 3.487

6.  Faecal neutrophil elastase-antiprotease balance reflects colitis severity.

Authors:  Rachael Barry; David Ruano-Gallego; Shiva T Radhakrishnan; Scott Lovell; Lu Yu; Olga Kotik; Izabela Glegola-Madejska; Edward W Tate; Jyoti S Choudhary; Horace R T Williams; Gad Frankel
Journal:  Mucosal Immunol       Date:  2019-11-26       Impact factor: 7.313

7.  The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study.

Authors:  Tiziana Larussa; Danilo Flauti; Ludovico Abenavoli; Luigi Boccuto; Evelina Suraci; Raffaella Marasco; Maria Imeneo; Francesco Luzza
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

8.  Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6.

Authors:  Giusy Sammarco; Mohammad Shalaby; Sudharshan Elangovan; Luciana Petti; Giulia Roda; Silvia Restelli; Vincenzo Arena; Federica Ungaro; Gionata Fiorino; Anthony J Day; Silvia D'Alessio; Stefania Vetrano
Journal:  Cells       Date:  2019-09-12       Impact factor: 6.600

9.  Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience.

Authors:  Sami Hoque; Amy Puenpatom; Simona Boccaletti; Chloe Green; Christopher M Black; Jenna Roberts; Ivana Rajkovic; Gary Milligan
Journal:  BMJ Open Gastroenterol       Date:  2020-11

10.  Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis.

Authors:  Matthew J Brookes; John Waller; Joseph C Cappelleri; Irene Modesto; Marco D DiBonaventura; Natalie Bohm; Ruth Mokgokong; Olivia Massey; Robert Wood; Danielle Bargo
Journal:  BMJ Open Gastroenterol       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.